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Background: Norway has a low, but increasing prevalence of resistance and few antimicrobial stewardship
initiatives. When developing stewardship interventions, an understanding of the determinants of antimicrobial
prescribing is needed. We report on the first qualitative study investigating factors influencing doctors’ antimicrobial
prescribing practices in Norwegian hospitals.
Methods: Qualitative semi-structured interviews were conducted with 15 Norwegian hospital doctors prescribing
antimicrobials to adult patients. Interviews were transcribed verbatim and thematic analysis was applied to analyse
the data.
Results: Colleagues, in particular infectious disease specialists, microbiology test results and the newly published
national guideline on antimicrobials were identified as key factors influencing antimicrobial prescribing practices.
Delayed availability was a barrier for the utilization of microbiology test results and increasing clinical experience
overrides the influence of the national guideline.
Patient assessment, informal training by experienced colleagues, and infectious disease specialists replacing
managers in promoting prudent prescribing policies, also influenced prescribing practices.
Conclusion: This study identified the following contextual factors that need to be addressed when developing
antimicrobial stewardship programs in Norway: a common work practice for seeking collegial advice, logistics of
microbiology test results, and formal leadership and systematic training on prudence. Other countries initiating
stewardship programmes may benefit from performing a similar mapping of facilitators and barriers, to identify
important stakeholders and organisational obstacles, before developing sustainable and tailored antimicrobial
stewardship interventions.
Keywords: Antimicrobial use, Prescription practices, Hospital doctors, Antimicrobial resistance, Antimicrobial
guideline, Qualitative researchBackground
Though several countries have antimicrobial stewardship
programmes (ASPs) in place [1], many are initiating
stewardship activities, including such diverse countries
as India and Norway [2, 3]. In Norway antimicrobial
resistance (AMR) rates are low, but increasing, and
antimicrobial consumption, in particular broad spectrum
antimicrobials, has increased the last 20 years [4, 5]. In* Correspondence: brita.skodvin@helse-bergen.no
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creativecommons.org/publicdomain/zero/1.0/2013, overall sales of antimicrobials were 20.0 Defined
Daily Doses (DDD) per inhabitant per day. Hospitals are
responsible for around 7 % of the total antimicrobial
consumption [4].
The increasing national and international threat of
AMR has highlighted the need for interventions to
contain the low rates of AMR in Norway [3]. In an up-
coming Norwegian action plan for containment of AMR
mandatory components of ASPs and audits assessing the
quality of the prescriptions will be addressed, filling the
present void. “The National Advisory Unit for Antibioticarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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in Norwegian hospitals.
The Norwegian healthcare system operates predomin-
antly through government led health services and hospitals.
The country has a dispersed geography with many small -,
some medium- and a few large university hospitals. Many
of the smaller hospitals lack on-site microbiology laborator-
ies and infectious disease specialists (ID-specialists). Fur-
thermore, clinical microbiologists and -pharmacists are not
established professions, leaving antimicrobial prescribing
decisions to be made by doctors alone. In July 2013, a new
national guideline on antimicrobials was published, re-
placing local guidelines [6]. The guideline was developed
with contribution from over 80 hospital doctors, mainly
ID- specialists and is only available online.
ASPs have proven to be efficient in the short term, with
no clear evidence of what are the successful components
for a sustainable change in prescribing practices [7, 8]. A
systematic review of antimicrobial prescribing studies in
hospitals suggests that sustainability of ASPs may be
improved with a better understanding of behavioural
determinants of prescribing [9]. Another review concludes
that cultural, contextual and behavioural factors need to be
addressed to influence antimicrobial use [10]. Both qualita-
tive and quantitative studies have been performed on the
topic [11–18], however, we report on the first qualitative
study in Norway investigating factors influencing anti-
microbial prescribing practices among hospital doctors.
Methods
Study design
An explorative qualitative design using a semi-structured
interview methodology was chosen to investigate factors
influencing antimicrobial prescribing practices among
hospital doctors [19, 20]. Face to face interviews were pre-
ferred over focus groups to reduce bias of social pressures
between informants’ positions and specialities, preventing
them from expressing their opinions freely.
Study interview guide development
An interview guide was developed based on a literature
review and individual face to face conversations with six
key informants (hospital doctors), purposively sampled
from two hospitals in Western Norway [10, 13, 21, 22].
Open ended questions were used to conduct the conversa-
tions. The six dimensions (structural, political, cultural,
educational, emotional and physical) of healthcare quality
identified by Bate, Mendel and Robert were applied as a
framework to analyse data from the conversations and
structure the interview guide [23]. Analysis of the key in-
formant conversations identified two additional dimen-
sions to the guide (patient- and hospital characteristics)
and informed the detailed questions of the interview guide
(full interview guide in additional file 1).Recruitment of participants
Author IS (study project manager) requested the Directors
of development and research in all health trusts in Norway
via e-mail to invite individuals to participate in the study.
Some disseminated the invitation by e-mail asking for
volunteers, and others selected candidates from the list
of employees. Only doctors prescribing antimicrobials
to adult patients and working in hospital wards were
qualified for inclusion, including ID-specialists.
Initially, 55 doctors were identified by the Directors of
development and research as eligible to participate in
the study. To secure a rich diversity, 22 of them were
consecutively selected based on age, gender, specialty,
clinical experience, hospital (local-, regional- or university
hospital) and geography. Author BS informed the 22
doctors about the study and personally invited them to
participate by e-mail. Seven doctors did not respond to
the invitation. Saturation of empirical themes was reached
after ten interviews, however, to fulfil the criteria of diver-
sity, 15 doctors were interviewed [24, 25].
Interviews
Interviews took place between October 2013 and January
2014. All interviews were recorded and transcribed verba-
tim. Author BS, an ID-specialist and PhD student trained
in qualitative methods conducted and transcribed the in-
terviews. They were performed at the participants’ work
place within working hours. The participants were not in-
formed about the interviewers’ background, but were told
if they asked.
Analysis
Thematic analysis was applied to the transcripts using a
combined deductive and inductive approach [20, 26, 27].
Two researchers (BS, IS) read all the transcripts independ-
ently, and a third researcher (KA) read a major sample of
them. The three researchers independently listed the
emerging themes and through discussions agreed on pre-
liminary themes. One researcher (BS) identified quotes in
all the transcripts reflecting each theme and developed
preliminary subthemes. Subsequently quotes reflecting
each subtheme were categorized, and corresponding de-
scriptions were developed. Themes, subthemes and de-
scriptions were then discussed by the three researchers,
leading to reorganising, renaming and elimination of some
themes and subthemes. This procedure was then repeated
for themes and subthemes requiring further analysis. Final
conclusion on themes, subthemes and descriptions were
conducted through discussions and agreements between
all three researchers (Table 2).
Ethics
The Regional Committee for Medical and Health Research
Ethics considered the study to only need approval by the
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Protection Authority, from which it was approved (2013/
6960). All interviewees signed an informed consent.Results
Fifteen doctors from 13 hospitals and five major medical
fields (internal medicine, surgery, oncology, neurology and
intensive care) were interviewed. Two of the interviewees
were ID- specialists (Table 1). Duration of interviews
ranged from 36 to 68 min (average 54 min).
The participants describe an antimicrobial prescribing
practice in Norwegian hospitals which mainly involve in-
terns and residents (doctors training to become specialists).
In smaller hospitals, interns are the only doctors present in
the emergency departments, whereas in bigger hospitals
they work alongside residents. Normally interns discuss
patients with residents who, when lacking sufficient
knowledge and experience, discuss the patients with
consultants. Consultants receive updates on hospitalized
patients on morning and afternoon handover meetings.
Antimicrobial treatment initiated in patients hospitalized
during daytime is evaluated on evening rounds by a resi-
dent or a consultant on call. At hospital wards, consultants
in general play the role of supervisors and attend ward
rounds at variable frequencies. ID-specialist services
vary greatly between hospitals. Some have ID-specialist
consultants on-site, who perform counselling by phone
or bedside, and may do systematic ward rounds, for in-
stance at intensive care units. Other hospitals lacking
ID-consultants obtain advice by phone from hospitals
possessing this expertise. Nationwide ID-specialists are
available by phone day and night all year.Table 1 Demographics of participants
Variable numbers
Male/female 7/8
Age 25–35 years 6
Age 36–45 years 5
Age 46–55 years 2
Age 56–65 years 2
Interns/residents/consultants 2/5/8
Internal medicine 4
ID-specialists 2
Surgerya 4
Other medical fieldsb 3
Health trusts represented 9/20
Local hospitals represented 6
Regional hospitals represented 5
University hospitals represented 4
aOrthopedic, gastrointestinal, urology, gynecology
bOncology, neurology, intensive careIn the following, we will use the six main themes that
emerged from the analysis to describe the key factors
influencing hospital doctors’ practice when prescribing
antimicrobials; colleagues, microbiology test results,
national guideline, training, patient assessment and
leadership (Table 2).Colleagues
In daily clinical work, more experienced doctors are fre-
quently consulted regarding antimicrobial therapies. When
local expertise is insufficient, an ID-specialist is the desired
colleague to seek advice from, mainly by phone, exemplified
by the following quote: “Concerning antibiotic treatment,
we follow a simple algorithm, but when things get com-
plicated, we collaborate with the ID-specialists, and in-
tensive care doctors, of course” (C1). The ID-specialist
can also exert influence during handover meetings,
through discussions regarding antimicrobial treatment
of hospitalized patients.
Other specialities can also be influential, including pul-
monologists and nephrologists when treating patients
with pneumonia or kidney failure. Microbiologists may
impact antimicrobial prescription when clinicians phone
them for test results and choice of antimicrobials is dis-
cussed. One interviewee described the involvement of dif-
ferent colleagues in antimicrobial prescribing as follows:
“Working as a junior doctor, I first phone the consultant on
call. However, often you end up phoning the resident on
call at the department of internal medicine. Occasionally
they can give you some advice, or they consult their consul-
tants. A couple of times I have called the ID-specialist at
the University hospital“(C2).Microbiology test results
Doctors actively use microbiology test results when
selecting antimicrobial therapy. Firstly, they emphasize
obtaining specimens before starting antimicrobial treatment
(M1). Secondly, they put a great effort into checking up on
results, in order to adjust treatment. Lack of availability and
timeliness is perceived as a limiting factor since test results
are first made available when resistance data are complete
(M2). In hospitals without a microbiology laboratory there
is also the delay of specimen transport and transfer of re-
sults into separate electronic systems, leading to prolonged
broad spectrum antimicrobial treatment, and patients being
discharged before results are available. Clinicians try to
overcome these obstacles by phoning the laboratory for
preliminary test results (M2, M3), and laboratories phone
clinical departments about important results such as
positive blood cultures. However, opening hours of the
laboratories are usually limited from morning to afternoon,
six to seven days a week.
Table 2 Description of the identified themes
Quotes Description Subthemes Themes
Concerning antibiotic treatment, we follow a simple
algorithm, but when things get complicated, we
collaborate with the ID-specialists, and intensive care
doctors, of course. [Consultant, gastro surgery] (C1)
The ID-specialist is the primary collaborator when treating
difficult infectious disease patients
ID-specialists Colleagues
Working as a resident, I first phone the consultant on call.
However, often you end up phoning the resident on call at
the department of internal medicine. Occasionally they can
give you some advice, or they consult their consultants. A
couple of times I have called the ID-specialist at the
University hospital. [Resident, oncology] (C2)
When the ID-specialist is not readily available several
other colleagues contribute to the choice of AB-treatment;
More experienced colleagues in the wards and on call,
internists, especially pulmonary doctors and microbiologists
can provide input on AB treatment
Other
colleagues
We put great effort into obtaining specimens, preferably
several specimens, in order to be sure that we use an
adequate antifungal and not just Fluconazole. Our experience
is that we more frequently, more often use other drugs, but
then again, in accordance with resistance data. [Consultant,
intensive care] (M1)
Microbiology test results are considered an important
contribution to the treatment; Great effort is put into
obtaining cultures and to check up on the preliminary
results in order to adjust treatment accordingly.
Priority Microbiology
test results
If it has not been transferred to the electronical medical
record, it’s not there. But it’s there. They are just waiting for
the final resistance data. In other words, the test results are
there, but it takes two or three days before they show up
on the screen. So maybe.., yes. No, people just need to
know that they can make a phone call. [Resident, internal
medicine] (M2)
Microbiology reports become available very late to the
clinician. The clinician tries to solve this by phoning to
the lab, and vice versa.
Availability
Our systems do not let us check up on what tests have
been obtained. You actually have to call and ask: “Have
you received the specimen so and so?” Or else, you would
have to wait for the results for another two to three days.
Once it is available, it is shown in the electronical medical
record in the section for laboratory results. [Consultant,
ID-specialist] (M3)
It’s perfectly okay as long as you use it, you’re safe. No
one can hold anything against you as long as you treat
according to the guideline. It really makes you feel safe
when on call. [Intern, internal medicine] (N1)
When knowledge and experience are insufficient, the
guideline is perceived as a useful and supportive tool.
The guideline’s significance however decreases with
increased experience and knowledge.
Experience National
guideline
Well, I try to stick to the guideline, most of the time. If I
do not, I normally have good reasons not to. But, I do
not always agree with it. And I try to justify it if I do not
follow it. [Consultant, ID-specialist] (N2)
The computer works incredibly slow here. It is very
annoying when logging on, that is. You just sit there
and twiddle you thumbs for… That’s when it would
have been great to have an app, just great. [Intern,
internal medicine] (N3)
Suboptimal IT-systems impairs the availability of the
guidelines. Distribution on several platforms would
promote the availability
Availability
..we have checklists for items they have to check out. And
the antibiotic guideline is one among them. That’s how we
somehow tell them this is to be complied with, and also
to be sure that they know how to find it. [Consultant,
internal medicine] (N4)
The guideline is used to promote AB policy Promoting
policy
Education mainly takes place at the end- of- shift meetings,
that is. Much is embedded in each of the cases we discuss.
[Consultant, orthopedics] (T1)
Training is mainly informal and unsystematic; Lectures are
held irregularly. However, training comes mainly from
discussing clinical cases and observing more experienced
colleagues
Informal and
unsystematic
Training
Discussing with ID-specialists, but also observing how other
doctors on call treat patients and discussions at the end-
of- shift meeting. [Resident, internal medicine] (T2)
There is no scheduled training, no. You’re expected to
possess that knowledge, which you don’t have as an
intern, because, it’s too theoretical. To have a guideline,
-it is presented to you early on.. Just check the guideline,
just use it. And you end up reading about it yourself. [Resi-
dent, internal medicine] (T3)
The national guideline is used as a substitute for the
formal training
Guideline
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Table 2 Description of the identified themes (Continued)
Sometimes, in the emergency department when your
findings are inconclusive, you broaden the initial therapy.
They keep telling me: “Try not to use broad spectrum as
much,” but once in a while you just have to, and it’s is
okay to a certain degree. Patient first, so to speak. [Intern,
internal medicine] (P1)
When patient history, findings and diagnostic tools are
inconclusive it feels safer to prescribe antimicrobials, than
not. For the same reason broad- spectrum therapy often
is chosen
Inconclusive
conditions
Patient
assessment
It depends on clinical judgement, and the patient’s clinical
condition. If he is in very bad condition, fulfilling all the
sepsis criteria, and has an unstable blood pressure and
everything, only the broadest spectrum. [Consultant,
urology] (P2)
Severity of disease determines the intensity of treatment;
Threshold for starting AB, prescribing broad spectrum
agents and prolonging therapy is lowered
Severity of
disease
No, I’m not quite sure whether I can call it politically
incorrect, but severely ill neutropenic patients are given
Meropenem although it’s possible that they shouldn’t be
given any antibiotics at all, but at the same time I think
that… [Consultant, internal medicine] (P3)
I may have become better at waiting. In most cases, you
have much more time than you expect. And in that case,
you can wait until you know some more. [Resident, internal
medicine] (P4)
Clinical experience facilitates dealing with the challenging
conditions and to adopt a restrictive approach in
antimicrobial treatment
Clinical
experience
No, it’s not on the agenda, that’s my experience. My
impression is that we are free to do as we like. But, it
doesn’t mean that we can go crazy. I think it would have
been pointed out if we were to give everyone everything. I
think it would have been put on the agenda. [Consultant,
ID-specialist] (L1)
AB policy is to a small extent on the agenda of the
hospital leaders
Priority Leadership
NN is the leader of the infectious disease department, and
he is on every end-of-shift meetings and so on. And it’s
very.. people always say: “We give this and that, and I’m
not sure that the ID-specialists agree.” And they sit there,
and give corrections, or say: “Yes, but we have to resort to
that,” or.. [Resident, internal medicine] (L2)
The ID-specialists advocates prudent AB use in discussions
about clinical cases, typically on morning sessions.
ID-specialists
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The national guideline is considered a useful tool by in-
terns and inexperienced residents (N1). One less experi-
enced doctor refers to the time period from when the
local guideline was outdated until the new national
guideline was published as follows: “When I was told
that the guideline was outdated I panicked. What am I
going to do, what am I going to use now? Fortunately,
the new ones were then published.”
More experienced residents use the guideline as a ref-
erence for checking dosages and treating uncommon
infectious diseases, whereas consultants, including ID-
specialists, consider the guideline as less significant and
emphasize the need to adjust treatment to individual
patients (N2). They consider the guideline as a tool and
not a law, and may point out its weaknesses.
The availability of the guideline is limited due to sub-
optimal IT-systems. Computers may be slow and the
guideline hard to find, which is time consuming. Some
participants therefore expressed a desire to have a print
out, a pocket guide or a smart phone application (N3).
Some doctors describe that the guideline is used as a tool
to promote antimicrobial policy. Informal leaders (ID-
specialists), and to a lesser extent formal leaders (hospital
managers), point to the guideline as a national and localstandard for antimicrobial treatment. This is especially
stressed to new employees e.g. interns and locums (N4).
Training
Lectures and courses in antimicrobial use are held,
though irregularly. However, input from more experienced
clinical colleagues is the most valued type of training (T1).
Inexperienced doctors empasize supervision by experi-
enced doctors when on call in the emergency room,
and experienced doctors highlight discussions with
ID-specialists. Learning may also come from sheer obser-
vation of how more experienced colleagues prescribe anti-
microbials (T2).
The national guideline is used as a substitute for formal
training. Experienced doctors or managers may refer to it
as a useful tool to the less experienced. One resident said:
“There is no scheduled training, no. You’re expected to
possess that knowledge, which you do not as an intern,
because it’s too theoretical. To have a guideline, -it is
presented to you early on… Just check the guideline,
just use it. And you end up reading about it yourself” (T3).
Patient assessment
The influence of patient assessment on antimicrobial
prescribing becomes evident in several settings. Firstly,
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clusive, or when infection is difficult to distinguish from
cancer or rheumatic disorders, it feels safer to prescribe
antimicrobials than not, and broad spectrum therapy is
often chosen to secure adequate coverage (P1). Secondly,
severely ill patients suffering from sepsis or significant
comorbidities are often treated more aggressively with
regard to initiation, spectrum, de-escalation and duration of
antimicrobial therapy (P2, P3). Clinical experience facilitates
dealing with these patients. According to the interviewees,
experience makes it easier to identify the severely ill
patients and to prescribe antimicrobials prudently (P4).
The confidence to rely on narrow spectrum antimicrobials
as adequate treatment for several severe conditions is only
acquired with experience.
Leadership
Hospital managers are not perceived as promoting anti-
microbial policies. An ID-specialist said: “No, it’s not on
the agenda, not that I know. My impression is that we
are free to do as we like, but that doesn’t mean that we
can “go crazy”. I think it would have been pointed out if
we were to give everyone everything. Then it would have
been put on the agenda” (L1). However, ID-specialists fill
the void of managers and advocate prudence by promoting
the guideline and the use of narrow spectrum antimi-
crobials, typically on handover meetings while discussing
clinical cases (L2).
Discussion
When exploring factors influencing hospital doctors’
antimicrobial prescribing practices the main themes
identified were microbiology test results, colleagues
and the antimicrobial guideline. Some of these results
differ from what has been found in previous studies
[11, 13, 28], and some have implications for the successful
implementation of an ASP.
The most interesting finding was the participants’
emphasis on microbiology test results when prescribing
antimicrobials and their frustration over delayed results.
This has to our knowledge not been highlighted in previ-
ous studies. Experienced hospital doctors in Germany
viewed microbiologists and laboratories as helpful in
navigating antimicrobial treatment, but delayed results
were not mentioned as a challenge [29]. A reason why
delay came up as a major issue in our study may be the
dispersed geography in Norway. Transferrals of specimens
between hospitals and results back to the clinicians pose a
major logistical challenge. Action to improve the line of
communication between the laboratories and the clinics,
both electronically and orally, is required to enhance
support of clinical antimicrobial decision making. Fu-
ture research should explore how leaders and staff at
microbiology laboratories perceive the interaction withclinicians, as a basis for possible interventions on these
lines of communication. Furthermore, studies show that
antimicrobial stewardship teams can decrease time to
appropriate therapy by close follow up of microbio-
logical test results [30, 31], so establishing such teams
in Norwegian hospitals is highly relevant.
Another major finding was the influence of colleagues
on antimicrobial prescribing practice. Two studies con-
ducted in Ireland and UK found a hierarchical system
where senior colleagues had significant influence on
prescribing practices of the doctors [28, 15]. Another
study from the UK report on a prescribing etiquette
where clinical leaders and senior doctors overrule the
ID-specialists’ advice on antimicrobials [11]. On the
contrary, our interviewees spoke of several colleagues
as legitimate advisers, the ID-specialist being regarded
as the superior. In accordance with our findings, a
Swedish study found that all categories of doctors per-
ceived the ID-specialists as important for antimicrobial
prescribing and –resistance [12], and may express what
is described as egalitarian Scandinavian work systems
with a corresponding low consumption of antimicrobials
[10]. Since our interviewees are responsive to advice from
ID-specialists and ID-specialists are found to improve ap-
propriateness of antimicrobial prescribing, they should be
included in multidisciplinary antimicrobial stewardship
teams [32]. However, many Norwegian hospitals lack ID-
specialists, as well as clinical pharmacists and microbiolo-
gists, i.e. the traditional participants of ASP teams [33]. As
a consequence, ASP teams may have to be staffed differ-
ently in the Norwegian model. Studies have shown that
antimicrobial stewardship initiatives can be developed
without the traditional staffing, structures and resources
[34, 35]. The integration of nurses and other medical spe-
cialties should therefore be further explored in Norway.
A third major finding was that the doctors’ attitudes
towards the national guideline correspond with level of
clinical experience. Whereas interns and inexperienced
residents are dependent on the guideline, senior doctors
are more sceptical to it, which is in accordance with
other studies [36, 37]. One interviewee, an ID-specialist,
reported that he did not adhere to the guideline even
though he had participated in developing it. This lack of
adherence among senior doctors may be due to clinical
autonomy and experience [11, 38]. In Norway it may
also be explained by a gap in exposure to ASP interven-
tions. Being on the brink of initiating nationwide ASP
programmes, tailored audit and feedback to experienced
doctors on prescribing and application of the guideline,
may favourably be integrated in the programmes.
Furthermore, participants in the study report that their
managers do not promote prudent use of antimicrobials.
In hospitals with ID-specialists they may take the place
of managers and promote prudence. However, when
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essential to maintain the program [33]. Providing
knowledge on AMR to raise awareness supplemented
with local surveillance reports on antimicrobial use and
-resistance, may be a useful strategy to engage with
Norwegian hospital managers [39]. Another way to
promote prudent antimicrobial prescribing practice
could be to introduce formal and systematic training
programmes [40, 41], especially for interns. Improved
availability of the guideline is crucial and work is under
way to provide access to the guideline in pocket guide
and smart phone application formats.
The study has a few limitations. As interviewees were
recruited by the Directors of development and research
there may be a bias towards candidates with a special
interest in antimicrobials.
Furthermore, the role of author BS (conducting inter-
views), being an ID-specialist, may affect the response
from the participants and the interpretation of the results.
However, this was tentatively handled by writing down
preconceptions before conducting the interviews and
by involving three authors with different backgrounds
in crucial steps of the data analysis.
The sample of 15 interviewees met the methodological
requirement of saturation of themes and diversity [24].
The sample addresses a wide range of constituencies as
hospital size, age and professional background, securing
diversity. ID-specialists’ prescribing practices differs sig-
nificantly from other doctors’. We considered it important
to include them in order to obtain a comprehensive
picture of the antimicrobial prescribing practices in
Norwegian hospitals.Conclusion
Our study has identified several contextual factors that
influence antimicrobial prescribing in Norway, many which
differ from those reported from other countries. These
factors, such as a common work practice for seeking
collegial advice, logistics of microbiology test results,
and formal leadership and systematic training on prudence,
need to be addressed when developing ASPs. This dem-
onstrates the value of conducting a qualitative mapping
of contextual factors before establishing antimicrobial
stewardship initiatives. Other countries planning to im-
plement ASPs may benefit from a similar mapping of
facilitators and barriers, to identify important stake-
holders and organisational obstacles, before developing
sustainable and tailored ASP interventions.
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